packageRilonacept

rilonacept

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Rilonacept is an anti-inflammatory interleukin inhibitor used for pericarditis and cryopyrin-associated periodic syndromes. It is approved and in use, mainly in the United States, but its marketing applications in the European Union were withdrawn.

Summary written by glm-5.3-flash from Wikidata Q7334300 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:rilonacept
ATC codes:L04AC04
DrugBank:DB06372
Wikidata:Q7334300
molar mass:251000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown